A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease

Salim S. Hayek(Rush University Medical Center), Jochen Reiser(Rush University Medical Center), Melissa Tracy(Rush University Medical Center), Ha Won Lee(St. Jude Children's Research Hospital), Cheryl A. Winkler(National Cancer Institute), Sanja Sever(Harvard University), Adrienne Tin(Merck & Co., Inc., Rahway, NJ, USA (United States)), Andrew S. Levey(Tufts Medical Center), Morgan E. Grams(Johns Hopkins University), Vasil Peev(Rush University Medical Center), Jeffrey B. Kopp(National Institutes of Health), Eunsil Hahm(Rush University Medical Center), Nikolina Stojanović(Harvard University), Kwi Hye Koh(Rush University Medical Center), Josef Coresh(Optimal Solutions (United States)), Martin Zeier(Heidelberg University), Ranadheer R. Dande(Brigham and Women's Hospital), Lesley A. Inker(Tufts University), Garrett Garborcauskas(Broad Institute), Beata Samelko(Rush University Medical Center), Changli Wei(Rush University Medical Center), Mehmet M. Altintas(The University of Texas Medical Branch at Galveston), Yi‐An Ko(Emory University), Arshed A. Quyyumi(Emory University), Barry I. Freedman(Wake Forest University), Karl Skorecki(Bar-Ilan University), Jing Li(Rutgers, The State University of New Jersey), Hyun Lee(Korea Institute of Industrial Technology), Vineet Gupta(The University of Texas Medical Branch at Galveston), Michael S. Lipkowitz(Georgetown University), Nicholas J. Tardi(Rush University Medical Center)

Nature Medicine

June 26, 2017

Cited by 204

|Annals of Internal Medicine|2009|25.7k

|Data Archiving and Networked Services (DANS)|2002|11.7k

|Journal of the American College of Cardiology|2020|11.1k

|Annals of Internal Medicine|2006|5.8k

|JAMA|2007|4.9k

Related Papers